CA
ATRS

Corrado Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Corrado Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,850
Closed -$26K – 85
2019
Q2 		$26K Buy
+7,850
New +$22.7K 0.02% 82
2015
Q3 		– Sell
-11,250
Closed -$23K – 88
2015
Q2 		$23K Buy
+11,250
New +$27.3K 0.01% 90
2015
Q1 		– Sell
-13,750
Closed -$35K – 87
2014
Q4 		$35K Hold
13,750
– – 0.02% 69
2014
Q3 		$25K Hold
13,750
– – 0.01% 70
2014
Q2 		$37K Hold
13,750
– – 0.02% 70
2014
Q1 		$48K Hold
13,750
– – 0.02% 68
2013
Q4 		$61K Hold
13,750
– – 0.03% 71
2013
Q3 		$56K Buy
+13,750
New +$60.1K 0.03% 67

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Corrado Advisors's ATRS Position: Q3 2019 in Review

Corrado Advisors sold out of Antares Pharma, Inc. (ATRS) in Q3 2019, closing a stake of 7,850 shares — an estimated $26K sold.

Corrado Advisors first reported a position in ATRS in Q3 2013 and held it in 8 quarters. The position peaked at $61K in Q4 2013. 135 funds tracked by Wall St. Rank hold ATRS as of Q3 2019.

  • Corrado Advisors reported no remaining Antares Pharma, Inc. position as of Q3 2019 after selling out during the quarter.
  • Corrado Advisors sold 7,850 Antares Pharma, Inc. shares in Q3 2019, an estimated $26K.
  • Corrado Advisors first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 8 quarters.
  • Corrado Advisors's Antares Pharma, Inc. position peaked at $61K in Q4 2013.
  • 135 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2019.

Based on Corrado Advisors's 13F filing for Q3 2019, filed 8 Oct 2019.